n-formylmethionine leucyl-phenylalanine has been researched along with Hyperparathyroidism in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fadda, GZ; Kiersztejn, M; Massry, SG; Smogorzewski, M; Thanakitcharu, P | 1 |
1 other study(ies) available for n-formylmethionine leucyl-phenylalanine and Hyperparathyroidism
| Article | Year |
|---|---|
Decreased O2 consumption by PMNL from humans and rats with CRF: role of secondary hyperparathyroidism.
Topics: Adult; Animals; Calcium; Female; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Renal Dialysis; Time Factors; Verapamil | 1992 |